(TNYA) Tenaya Therapeutics - Performance -90.3% in 12m
Compare TNYA with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-76.53%
#123 in Group
Rel. Strength
1.48%
#7839 in Universe
Total Return 12m
-90.33%
#190 in Group
Total Return 5y
-97.30%
#159 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -
23th Percentile in Group
12m Total Return: TNYA (-90.3%) vs XBI (-14.9%)
5y Drawdown (Underwater) Chart
Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| UTHR NASDAQ United Therapeutics |
7.21% | 14% | 161% | 12.1 | 11 | 1.43 | 74.6% | 16.1% |
| HLN NYSE Haleon |
7.98% | 32.4% | 49.3% | 24.4 | 20.2 | 1.79 | 69.1% | 13.6% |
| AMGN NASDAQ Amgen |
-7.04% | -11.2% | 27.7% | 25.5 | 13.5 | 0.95 | 0.60% | 41% |
| LONN SW Lonza |
11.7% | 13.3% | 33.5% | 67.1 | 35.1 | 1.28 | 2.20% | -12.5% |
| BIM PA Biomerieux |
2.2% | 21% | -1.63% | 32.5 | 25.2 | 1.52 | -38.5% | -25.1% |
| KMDA NASDAQ Kamada |
13.3% | 27.1% | -5.64% | 27.5 | 25.1 | 1 | 32.5% | 3.93% |
| NBIX NASDAQ Neurocrine Biosciences |
27.3% | -15% | 1.88% | 32.3 | 21.6 | 0.27 | 68.0% | 31.9% |
| ERF PA Eurofins Scientific SE |
20% | 0.38% | 8.05% | 26.6 | 13.6 | 0.56 | -66.6% | -17.1% |
Performance Comparison: TNYA vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for TNYA
| Total Return (including Dividends) | TNYA | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -16.03% | 2.77% | 5.69% |
| 3 Months | -56.13% | -14.21% | -6.49% |
| 12 Months | -90.33% | -14.88% | 9.72% |
| 5 Years | -97.30% | -26.47% | 107.51% |
| Trend Score (consistency of price movement) | TNYA | XBI | S&P 500 |
| 1 Month | -9.10% | 57% | 89.4% |
| 3 Months | -74.8% | -82.3% | -72% |
| 12 Months | -91.2% | -53.1% | 49.3% |
| 5 Years | -76.5% | -53.9% | 84.1% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
| 1 Month | #160 | -18.3% | -20.6% |
| 3 Month | #190 | -48.9% | -53.1% |
| 12 Month | #190 | -88.6% | -91.2% |
| 5 Years | #154 | -95.7% | -98.0% |
FAQs
Does TNYA Tenaya Therapeutics outperforms the market?
No,
over the last 12 months TNYA made -90.33%, while its related Sector, the SPDR S&P Biotech (XBI) made -14.88%.
Over the last 3 months TNYA made -56.13%, while XBI made -14.21%.
Over the last 3 months TNYA made -56.13%, while XBI made -14.21%.
Performance Comparison TNYA vs Indeces and Sectors
TNYA vs. Indices TNYA is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -17.0% | -21.7% | -78.7% | -100% |
| US NASDAQ 100 | QQQ | -17.3% | -23.4% | -79.2% | -101% |
| US Dow Jones Industrial 30 | DIA | -16.9% | -18.7% | -77.7% | -96.6% |
| German DAX 40 | DAX | -17.4% | -31.1% | -104% | -115% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -17.2% | -18.9% | -78.0% | -96.6% |
| Hongkong Hang Seng | HSI | -19.9% | -30.9% | -88.2% | -98.6% |
| India NIFTY 50 | INDA | -13.3% | -19.2% | -80.6% | -92.4% |
| Brasil Bovespa | EWZ | -20.0% | -27.7% | -88.0% | -84.1% |
TNYA vs. Sectors TNYA is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -16.4% | -22.5% | -84.9% | -111% |
| Consumer Discretionary | XLY | -18.4% | -22.7% | -76.6% | -105% |
| Consumer Staples | XLP | -16.1% | -16.7% | -85.7% | -97.6% |
| Energy | XLE | -19.2% | -20.5% | -72.7% | -81.3% |
| Financial | XLF | -17.7% | -22.9% | -84.6% | -112% |
| Health Care | XLV | -12.9% | -13.0% | -73.5% | -84.3% |
| Industrial | XLI | -17.9% | -24.3% | -79.7% | -101% |
| Materials | XLB | -17.2% | -21.1% | -74.7% | -84.3% |
| Real Estate | XLRE | -16.2% | -22.9% | -81.1% | -104% |
| Technology | XLK | -17.8% | -25.7% | -76.5% | -96.4% |
| Utilities | XLU | -17.7% | -21.2% | -86.5% | -106% |
| Aerospace & Defense | XAR | -17.2% | -25.2% | -88.0% | -116% |
| Biotech | XBI | -9.27% | -18.8% | -57.7% | -75.5% |
| Homebuilder | XHB | -16.6% | -21.6% | -65.1% | -81.5% |
| Retail | XRT | -17.1% | -22.2% | -72.5% | -84.1% |